🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 6 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/06/2018 | 130,38 | 131,09 | 127,49 | 129,24 | -0,39% | 2,76% | 744.433 |
| 28/06/2018 | 124,55 | 132,56 | 124,28 | 129,74 | +4,72% | 6,65% | 1.184.296 |
| 27/06/2018 | 122,74 | 127,26 | 122,34 | 123,89 | +2,23% | 4,01% | 1.000.432 |
| 26/06/2018 | 120,37 | 122,21 | 119,20 | 121,19 | +1,07% | 2,50% | 419.505 |
| 25/06/2018 | 123,24 | 123,52 | 119,44 | 119,90 | -3,12% | 3,31% | 637.834 |
| 22/06/2018 | 125,38 | 125,38 | 122,50 | 123,77 | -0,63% | 2,30% | 725.197 |
| 21/06/2018 | 126,41 | 126,41 | 122,56 | 124,55 | +0,25% | 3,04% | 631.742 |
| 20/06/2018 | 122,82 | 124,62 | 122,21 | 124,24 | +1,65% | 1,97% | 301.043 |
| 19/06/2018 | 119,56 | 122,50 | 118,70 | 122,21 | +1,25% | 3,18% | 500.938 |
| 18/06/2018 | 118,30 | 121,65 | 118,18 | 120,70 | +0,95% | 2,94% | 298.639 |
| 15/06/2018 | 119,34 | 120,86 | 115,84 | 119,57 | -0,22% | 4,21% | 740.907 |
| 14/06/2018 | 116,03 | 120,06 | 115,55 | 119,83 | +3,80% | 3,89% | 596.797 |
| 13/06/2018 | 120,10 | 121,82 | 114,85 | 115,44 | -3,62% | 5,80% | 767.677 |
| 12/06/2018 | 120,48 | 121,38 | 118,14 | 119,78 | -0,32% | 2,69% | 500.617 |
| 11/06/2018 | 123,16 | 123,16 | 119,47 | 120,16 | -2,08% | 2,99% | 368.049 |
| 08/06/2018 | 123,51 | 124,78 | 122,08 | 122,71 | -1,13% | 2,19% | 263.694 |
| 07/06/2018 | 123,55 | 125,39 | 123,15 | 124,12 | +0,80% | 1,81% | 371.255 |
| 06/06/2018 | 124,77 | 125,58 | 120,77 | 123,14 | -0,99% | 3,85% | 420.146 |
| 05/06/2018 | 123,03 | 124,58 | 119,18 | 124,37 | +1,24% | 4,39% | 366.286 |
| 04/06/2018 | 123,52 | 124,22 | 119,63 | 122,84 | -0,04% | 3,72% | 581.729 |
| 01/06/2018 | 120,45 | 123,18 | 120,27 | 122,89 | +2,48% | 2,41% | 606.896 |
| 31/05/2018 | 120,01 | 122,02 | 118,86 | 119,92 | +0,37% | 2,64% | 386.644 |
| 30/05/2018 | 117,21 | 120,01 | 116,87 | 119,48 | +2,39% | 2,67% | 542.936 |
| 29/05/2018 | 117,52 | 118,37 | 115,48 | 116,69 | -1,16% | 2,46% | 554.478 |
| 25/05/2018 | 117,95 | 118,37 | 117,23 | 118,06 | -0,09% | 0,97% | 444.512 |
| 24/05/2018 | 119,13 | 119,98 | 117,50 | 118,17 | -0,69% | 2,08% | 366.927 |
| 23/05/2018 | 116,45 | 119,04 | 115,80 | 118,99 | +1,95% | 2,79% | 515.525 |
| 22/05/2018 | 116,33 | 118,02 | 114,80 | 116,71 | +0,93% | 2,77% | 672.298 |
| 21/05/2018 | 122,28 | 122,62 | 115,56 | 115,63 | -4,94% | 5,78% | 770.081 |
| 18/05/2018 | 119,44 | 121,75 | 118,85 | 121,64 | +2,01% | 2,43% | 1.994.613 |